These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 307695)

  • 41. Action of phorbol esters in cell culture: mimicry of transformation, altered differentiation, and effects on cell membranes.
    Weinstein IB; Lee LS; Fisher PB; Mufson A; Yamasaki H
    J Supramol Struct; 1979; 12(2):195-208. PubMed ID: 397370
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Epidermal growth factor and tumor promoters prevent DNA fragmentation by different mechanisms.
    Kanter P; Leister KJ; Tomei LD; Wenner PA; Wenner CE
    Biochem Biophys Res Commun; 1984 Jan; 118(2):392-9. PubMed ID: 6608349
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Changes in epidermal growth factor receptors associated with adenovirus transformation, chemical carcinogen transformation and exposure to a phorbol ester tumor promoter.
    Fisher PB; Lee LS; Weinstein IB
    Biochem Biophys Res Commun; 1980 Apr; 93(4):1160-6. PubMed ID: 6249279
    [No Abstract]   [Full Text] [Related]  

  • 44. Effects of epidermal growth factor, phorbol myristate acetate, and arachidonic acid on choriogonadotropin secretion by cultured human choriocarcinoma cells.
    Ilekis J; Benveniste R
    Endocrinology; 1985 Jun; 116(6):2400-9. PubMed ID: 2986949
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increase in urokinase plasminogen activator mRNA synthesis in human carcinoma cells is a primary effect of the potent tumor promoter, phorbol myristate acetate.
    Stoppelli MP; Verde P; Grimaldi G; Locatelli EK; Blasi F
    J Cell Biol; 1986 Apr; 102(4):1235-41. PubMed ID: 3958045
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interaction of tumor promoters and growth factors with cultured cells.
    Bowden GT; Matrisian LM; Lockyer JM; Magun BE
    Carcinog Compr Surv; 1982; 7():463-9. PubMed ID: 6279295
    [No Abstract]   [Full Text] [Related]  

  • 47. Tumor promoter modulation of epidermal growth factor- and nerve growth factor-induced adhesion and growth factor binding of PC-12 pheochromocytoma cells.
    Chandler CE; Herschman HR
    J Cell Physiol; 1980 Nov; 105(2):275-85. PubMed ID: 6970201
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Phorbol diester and epidermal growth factor receptors in 12-O-tetradecanoylphorbol-13-acetate-resistant and -sensitive mouse epidermal cells.
    Colburn NH; Gindhart TD; Hegamyer GA; Blumberg PM; Delclos KB; Magun BE; Lockyer J
    Cancer Res; 1982 Aug; 42(8):3093-7. PubMed ID: 6284358
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Calcium regulation of tissue plasminogen activator and prostaglandin biosynthesis in HeLa cells.
    Crutchley DJ; Smariga PE
    Biochim Biophys Acta; 1986 Apr; 886(1):26-32. PubMed ID: 3082371
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Growth arrest of AKR-2B cells maintained in the presence of epidermal growth factor or 12-O-tetradecanoylphorbol-13 acetate: evidence for two separate G1 arrest points.
    Moses HL; Proper JA; Volkenant ME; Swartzendruber DE
    J Cell Physiol; 1980 Mar; 102(3):367-78. PubMed ID: 6967071
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Stimulation of the synthesis of mouse epidermal histones by tumor-promoting agents.
    Raineri R; Simsiman RC; Boutwell RK
    Cancer Res; 1977 Dec; 37(12):4584-9. PubMed ID: 922741
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Different biological targets for resiniferatoxin and phorbol 12-myristate 13-acetate.
    Driedger PE; Blumberg PM
    Cancer Res; 1980 May; 40(5):1400-4. PubMed ID: 7189445
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulation of peptide binding to specific receptors on rat pituitary cells by tumor-promoting phorbol esters: decreased binding of thyrotropin-releasing hormone and somatostatin as well as epidermal growth factor.
    Osborne R; Tashjian AH
    Cancer Res; 1982 Nov; 42(11):4375-81. PubMed ID: 6127158
    [No Abstract]   [Full Text] [Related]  

  • 54. Phenotypic properties and tumor promotor-induced alterations in rat embryo cells transformed by adenovirus.
    Fisher PB; Goldstein NI; Weinstein IB
    Cancer Res; 1979 Aug; 39(8):3051-7. PubMed ID: 110444
    [No Abstract]   [Full Text] [Related]  

  • 55. Tumor-promoting phorbol esters induce angiogenesis in vitro.
    Montesano R; Orci L
    Cell; 1985 Sep; 42(2):469-77. PubMed ID: 2411423
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tumor promoter-induced adhesion of the DS19 clone of murine erythroleukemia cells.
    Yamasaki H; Weinstein IB; Fibach E; Rifkind RA; Marks PA
    Cancer Res; 1979 Jun; 39(6 Pt 1):1989-94. PubMed ID: 286635
    [No Abstract]   [Full Text] [Related]  

  • 57. Synergistic effect of tumor virus transformation and tumor promoter treatment on the production of plasminogen activator by chick embryo fibroblasts.
    Goldfarb RH; Quigley JP
    Cancer Res; 1978 Dec; 38(12):4601-9. PubMed ID: 214228
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Secretion of plasminogen activator by cerebral astrocytes and its modulation.
    Toshniwal PK; Tiku ML; Tiku K; Skosey JL
    J Neurol Sci; 1987 Sep; 80(2-3):307-21. PubMed ID: 3681335
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Similar effects of phospholipase C and phorbol ester tumor promoters on primary mouse epidermal cells.
    Jeng AY; Lichti U; Strickland JE; Blumberg PM
    Cancer Res; 1985 Nov; 45(11 Pt 2):5714-21. PubMed ID: 3931907
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Death of serum-free mouse embryo cells caused by epidermal growth factor deprivation is prevented by cycloheximide, 12-O-tetradecanoylphorbol-13-acetate, or vanadate.
    Rawson C; Cosola-Smith C; Barnes D
    Exp Cell Res; 1990 Jan; 186(1):177-81. PubMed ID: 2153551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.